1. Home
  2. ULCC vs RLAY Comparison

ULCC vs RLAY Comparison

Compare ULCC & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Frontier Group Holdings Inc.

ULCC

Frontier Group Holdings Inc.

HOLD

Current Price

$4.92

Market Cap

1.2B

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$7.71

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULCC
RLAY
Founded
1994
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
ULCC
RLAY
Price
$4.92
$7.71
Analyst Decision
Hold
Strong Buy
Analyst Count
10
8
Target Price
$5.67
$15.75
AVG Volume (30 Days)
3.3M
2.2M
Earning Date
02-06-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,729,000,000.00
$8,355,000.00
Revenue This Year
N/A
$19.96
Revenue Next Year
$16.65
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.77
N/A
52 Week Low
$2.89
$1.78
52 Week High
$10.26
$9.04

Technical Indicators

Market Signals
Indicator
ULCC
RLAY
Relative Strength Index (RSI) 48.02 47.92
Support Level $5.06 $7.36
Resistance Level $5.52 $8.64
Average True Range (ATR) 0.31 0.53
MACD -0.02 -0.01
Stochastic Oscillator 27.71 41.54

Price Performance

Historical Comparison
ULCC
RLAY

About ULCC Frontier Group Holdings Inc.

Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. Majority of revenue is from Domestic flight follow by International.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: